In the breast cancer sub-group, there was no significant difference in cancer-specific survival between patients with higher and lower pleural fluid OPN, VEGF, uPA, and PAI-1 concentrations or uPA/PAI-1 ratio. The gene discussed is PLAU; the disease is breast carcinoma.